Unknown

Dataset Information

0

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.


ABSTRACT: Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect, with a long-lasting immunological memory. Ionizing radiation (single dose of 15Gy, 5 × 2Gy or 5 × 5Gy) was delivered to primary C51 colon tumour-bearing immunocompetent mice in combination with L19-IL2 and response of secondary non-irradiated C51 or CT26 colon tumours was evaluated. 15Gy + L19-IL2 triggered a curative (20%) abscopal effect, which was T cell dependent. Moreover, 10Gy + L19-IL2 treated and cured mice were re-injected after 150 days with C51 tumour cells and tumour uptake was assessed. Age-matched controls (matrigel injected mice treated with 10Gy + L19-IL2, mice cured after treatment with surgery + L19-IL2 and mice cured after high dose RT 40Gy + vehicle) were included. Several immunological parameters in blood, tumours, lymph nodes and spleens were investigated. Treatment with 10Gy + L19-IL2 resulted in long-lasting immunological memory, associated with CD44+CD127+ expression on circulating T cells. This combination treatment can induce long-lasting curative abscopal responses, and therefore it has also great potential for treatment of metastatic disease. Preclinical findings have led to the initiation of a phase I clinical trial (NCT02086721) in our institute investigating stereotactic ablative radiotherapy with L19-IL2 in patients with oligometastatic solid tumours.

SUBMITTER: Rekers NH 

PROVIDER: S-EPMC5889197 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.

Rekers Nicolle H NH   Olivo Pimentel Veronica V   Yaromina Ala A   Lieuwes Natasja G NG   Biemans Rianne R   Zegers Catharina M L CML   Germeraad Wilfred T V WTV   Van Limbergen Evert J EJ   Neri Dario D   Dubois Ludwig J LJ   Lambin Philippe P  

Oncoimmunology 20180116 4


Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect, with a long-lasting immunological memory. Ionizing radiation (single dose of 15Gy, 5 × 2Gy or 5 × 5Gy) was delivered to primary C51 colon tumour-bearing immunocompetent mice in combination with L19-IL2 and response of secondary non-irradiated C51 or  ...[more]

Similar Datasets

| S-EPMC6769537 | biostudies-literature
| S-EPMC4948777 | biostudies-literature
| S-EPMC4741939 | biostudies-literature
| S-EPMC7993151 | biostudies-literature
| S-EPMC6783304 | biostudies-literature
| S-EPMC2966626 | biostudies-literature
| S-EPMC7296663 | biostudies-literature
| S-EPMC8566527 | biostudies-literature
| S-EPMC6168354 | biostudies-literature
| S-EPMC9891997 | biostudies-literature